A randomised, prospective study comparing selective laser trabeculoplasty with latanoprost for the control of intraocular pressure in ocular hypertension and open angle glaucoma
- 1 November 2005
- journal article
- research article
- Published by BMJ in British Journal of Ophthalmology
- Vol. 89 (11), 1413-1417
- https://doi.org/10.1136/bjo.2004.052795
Abstract
Aim: To compare 90°, 180°, and 360° selective laser trabeculoplasty (SLT, 532 nm Nd:YAG laser) with latanoprost 0.005% for the control of intraocular pressure (IOP) in ocular hypertension (OHT) and open angle glaucoma (OAG). Methods: A prospective, randomised clinical trial in the Department of Ophthalmology, St Thomas’s Hospital, London, and Clayton Eye Centre, Wakefield, West Yorkshire. 167 patients (167 eyes) with either OHT or OAG were randomised to receive 90°, 180°, and 360° SLT or latanoprost 0.005% at night and were evaluated at 1 hour, 1 day, 1 week and 1, 3, 6, and 12 months. Results: The mean follow up was 10.3 months (range 1–12 months). Early, transient, complications such as postoperative ocular pain, uveitis, and 1 hour IOP spike occurred in a number of eyes after SLT, with pain being reported more frequently after 360° than 90° treatments (p>0.001). Success rates defined in terms of both a 20% or more and a 30% or more IOP reduction from baseline measurements with no additional antiglaucomatous interventions were better with latanoprost than 90° (p30% reduction from baseline. Although success rates were better with 360° than 180° SLT treatments, differences did not reach statistical significance. There were no differences with regard to age, sex, race, pretreatment IOP, OHT versus OAG, laser power settings, and total laser energy delivered between eyes which responded, in terms of a >20% and a >30% IOP reduction, and those that did not respond with 180° and 360° SLT treatments. Conclusions: Success rates were higher with latanoprost 0.005% at night than with 90° and 180° SLT treatments. 90° SLT is generally not effective. 360° SLT appears to be an effective treatment with approximately 60% of eyes achieving an IOP reduction of 30% or more. Transient anterior uveitis with associated ocular discomfort is not unusual in the first few days after SLT. Late complications causing ocular morbidity after SLT were not encountered.Keywords
This publication has 19 references indexed in Scilit:
- The advanced glaucoma intervention study (AGIS)*113. Comparison of treatment outcomes within race: 10-year resultsOphthalmology, 2004
- A Comparison Between 90?? and 180?? Selective Laser TrabeculoplastyJournal of Glaucoma, 2004
- One-Year Follow-Up of Selective Laser Trabeculoplasty in Open-Angle GlaucomaOphthalmologica, 2003
- Wirksamkeit der selektiven Lasertrabekuloplastik bei der Behandlung von primärem OffenwinkelglaukomKlinische Monatsblätter für Augenheilkunde, 2003
- Acute ultrastructural changes of the trabecular meshwork after selective laser trabeculoplasty and low power argon laser trabeculoplastyLasers in Surgery and Medicine, 2003
- Selective Laser Trabeculoplasty as Primary Treatment for Open-angle GlaucomaArchives of Ophthalmology (1950), 2003
- Comparison of the morphologic changes after selective laser trabeculoplasty and argon laser trabeculoplasty in human eye bank eyesOphthalmology, 2001
- [Use of YAG-Selecta laser and argon laser in the treatment of open angle glaucoma].2000
- Ultrastructural changes of the trabecular meshwork of the monkey (Macaca speciosa) following irradiation with argon laser lightAlbrecht von Graefes Archiv für Ophthalmologie, 1984
- Argon Laser Therapy for Open-Angle GlaucomaArchives of Ophthalmology (1950), 1979